Safety and Synergy of Finerenone and Empagliflozin in Lowering Blood Pressure
Listen to this summary
This study aimed to evaluate the effectiveness and safety of combining finerenone and empagliflozin in lowering systolic blood pressure (SBP) in patients with chronic kidney disease and type 2 diabetes, particularly examining the differences between combination therapy and monotherapy. The findings indicated that combination therapy significantly improved SBP reduction in participants with baseline SBP ≥130 mm Hg, while the reduction in urinary albumin-to-creatinine ratio was largely independent of early SBP changes. The authors suggest that further research with ambulatory blood pressure monitoring is needed to validate these results.
This is one of 33,000+ journals available on OSLR. Try it free for 14 days.
Free 14-day trial. 33,000+ journals. Cancel anytime.

More in Internal Medicine
View all →Nov 20, 2026 · Reproductive biology and endocrinology : RB&E
Sirtuin 1-dependent oleanolic acid protection attenuates oxidative stress-induced granulosa cell dysfunction and ovarian damage.
Nov 20, 2026 · Journal of pain and symptom management
ACCOMPANI: A Psychosocial Nurse Intervention for African American Families in Pediatric Oncology.
Nov 20, 2026 · Mayo Clinic proceedings
Patient-Staff Interaction in ED by Real-time Location System: Novel Predictors of In-hospital Mortality Enhancing APACHE III/APS in ICU Patients.
Nov 20, 2026 · Journal of pain and symptom management
Perceived Clinical Utility of a Routine Family Experience Feedback Loop in Pediatric Palliative Care.
Nov 20, 2026 · Journal of pain and symptom management
Predictors of Clinician Success, Quality, and Resilience in Outpatient Pediatric Palliative Care.
Nov 20, 2026 · Kidney international
The effects of size and sex mismatch on kidney functional adaption following living donor kidney transplantation.
"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."
Dr. Jennifer Thompson
Portland, OR


